Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine plus artificial tears versus pranoprofen plus artificial tears for adenoviral conjunctivitis
2007-000059-33Phase 4Active
- Sponsor
- Dra. Carmen Ispa Callén
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olopatadine and pranoprofen in adenoviral conjunctivitis (2 arms), sponsored by Dra. Carmen Ispa Callén. Primary endpoints: Conjunctival injection, Conjunctival chemosis and 8 more. Started Mar 2007; status: active.
02
Drugs
olopatadinepranoprofen
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on 2007-000059-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000059-33.